PALLA PHARMA NORWAY AS
Independent Norwegian manufacturer of opiate APIs and finished dose formulations.
Overview
- 68
- Employees
- 213.2M NOK
- Revenue
- 2016
- Founded
Key Decision Makers
Andrew Howatson
Board Member
Karin Bjune Sveen
CFO
Halvor Weider
Board Member
Lars Markus Solheim
Board Member
+10 more contacts in Funnelfeedr
Description
Palla Pharma Norway (PPN) is an independent, 100% Norwegian-owned pharmaceutical company originally established in 1949. They specialize in the dedicated manufacturing of opiate-based Active Pharmaceutical Ingredients (API) and Finished Dose Formulations (FDF). PPN serves a global market, utilizing...
Tags
Keywords
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
14 contacts in FunnelfeedrAndrew Howatson
Board Member
Karin Bjune Sveen
CFO
Halvor Weider
Board Member
Lars Markus Solheim
Board Member
Morten Andresen
Board Member
Jørn Henning Isaksen
Board Member
Preben Hjallum
Board Member
Bernt-Kare Vildalen
CEO
Asgeir Ringdal
International Sales Director
Marit Satre Risberg
Quality and Regulatory Director
Marianne Erlund
Warehouse & Logistics Manager
Linda Haltli Haram
HR Manager
Oistein Tovsen
Production & Planning Manager
Other Contacts
Ille Elisabeth Einmann
HMS Specialist
Similar Companies
20 similar companies in Funnelfeedr
IMOONOR AS
Norwegian supplier of high-quality, natural Omega-3 health supplements.
VISTIN PHARMA AS
77 employeesDedicated Norwegian manufacturer supplying global Metformin API needs.
XELLIA PHARMACEUTICALS AS
30 employeesGlobal leader in fermentation-based non-beta-lactam anti-infectives.
GRINDEKS KALCEKS NORGE AS
Leading Baltic pharmaceutical manufacturer offering APIs, FDFs, and CDMO services.
HP HALDEN PHARMA AS
691 employeesLeading European sterile contract manufacturer specializing in advanced pharmaceutical production.
Browse More
PALLA PHARMA NORWAY AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo